Analyst Ratings for Morphic Therapeutic (MORF)

MORF Rating Summary

  |   Expand Research on MORF
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5.5 / 10   Percentile Rank: 58%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/9/2024 TD Cowen Ritu Baral Downgrade Hold
(Buy)		 N/A
(N/A)		 55.74
(56.99)		 2.24% Details
7/9/2024 RBC Capital Gregory Renza Downgrade Sector Perform
(Outperform)		 57.00
(70.00)		 31.84
(56.99)		 78.99% Details